Community Pharmacists’ Knowledge and Attitude Towards Opioid Pain Medication Use in Bahir Dar City, North-West Ethiopia

References

• CDC. Understanding the opioid overdose epidemic; 2021. Available from: https://www.cdc.gov/opioids/basics/epidemic.html#print. Accessed February 22, 2024.
   Google Scholar
• Gondora N, Versteeg SG, Carter C, et al. The role of pharmacists in opioid stewardship: a scoping review. Res Soc Adm Pharm. 2022;18(5):2714–2747. doi:10.1016/j.sapharm.2021.06.018
   PubMed Web of Science ®Google Scholar
• UNODC. Responding to global opioid crisis, UNODC launches strategy to protect public health. United Nations; 2018. Available from: https://www.unodc.org/unodc/en/frontpage/2018/June/responding-to-global-opioid-crisis--unodc-launches-strategy-to-protect-public-health.html. Accessed February 22, 2024.
   Google Scholar
• World Health Organization. Opioids Overdose; 2023. Available from: https://shorturl.at/ckoqz.Accessed February 22, 2024.
   Google Scholar
• Prempreet B, Brennan M, Grigoropoulos G, et al. Opioid knowledge and prescribing habits at a large tertiary care academic center. Cureus. 2022;14(8). doi:10.7759/cureus.27843
   PubMed Web of Science ®Google Scholar
• Kosobuski L, Donnell CO, Sharp CPK, et al. The role of the pharmacist in combating the opioid crisis: an update the role of the pharmacist in combating the Opioid crisis: an update. Sub Abuse Rehabil. 2022:127–138doi:10.2147/SAR.S351096
   PubMed Web of Science ®Google Scholar
• Sciences M. Assessment of community pharmacists’ knowledge, attitude and practice regarding non-prescription antimicrobial use and resistance in Thailand budh siltrakool submitted to the university of Hertfordshire in partial fulfilment of the requirements for the. 2017.
   Google Scholar
• Wilson HD, Dansie EJ, Kim MS, et al. Clinicians’ attitudes and beliefs about opioids survey (caos): instrument development and results of a national physician survey. J Pain. 2013;14(6):613–627. doi:10.1016/j.jpain.2013.01.769
   PubMed Web of Science ®Google Scholar
• Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A, van Dongen RT. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Heal. 2019;4(10):e498–e505. doi:10.1016/S2468-2667(19)30128-8
   PubMed Web of Science ®Google Scholar
• Kurth AE, Cherutich P, Conover R, Chhun N, Bruce RD, Lambdin BH. The opioid epidemic in Africa and its impact. Curr Addict Reports. 2018;5(4):428–453. doi:10.1007/s40429-018-0232-9
   PubMedGoogle Scholar
• Joranson DE, Gilson AM. Pharmacists’ knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J Am Pharm Assoc. 2001;41(2):213–220. doi:10.1016/s1086-5802(16)31232-3
   Google Scholar
• Kosobuski L, Sharp CP K-K, Chen N, Palombi L, Palombi L. The role of the pharmacist in combating the opioid crisis: an update. Substance Abuse Rehabil. 2022;Volume 13:127–138. doi:10.2147/SAR.S351096
   Web of Science ®Google Scholar
• Dunn KE, Barrett FS, Yepez-laubach C, et al. Brief opioid overdose knowledge (book): a questionnaire to assess overdose knowledge in individuals who use illicit or prescribed opioids. J Add Med. 2016;10(5):314–323. doi:10.1097/ADM.0000000000000235
   PubMed Web of Science ®Google Scholar
• Stephanie. Opening minds provider attitudes towards opioid use scale. Ment Heal Comm Canada. 2019. Available from: [email protected]. Accessed February 22, 2024.
   Google Scholar
• Shrestha S, B KC, Blebil AQ, Teoh SL. Pharmacist involvement in cancer pain management: a systematic review and meta-analysis. J Pain. 2022;23(7):1123–1142. doi:10.1016/j.jpain.2022.02.002
   PubMed Web of Science ®Google Scholar
• Webb K, Cernasev A, Li MS, Gatwood J, Cochran G, Hohmeier KC. An exploratory study of pharmacist perceptions of opioid interventions for acute pain. J Pharm Technol. 2021;37(1):36–44. doi:10.1177/8755122520967766
   PubMed Web of Science ®Google Scholar
• Kosobuski L, O’Donnell C, CPK-K S, Chen N, Palombi L. The role of the pharmacist in combating the opioid crisis: an update. Subst Abuse Rehabi. 2022;13:127. doi:10.2147/SAR.S351096
   PubMed Web of Science ®Google Scholar
• Ali MD, Mubarak FEA, Sherihan AG, et al. Attitude, and the practice of community pharmacists to dispense opioid‑related and opioid‑containing medication in eastern province, Saudi Arabia. J Pharm Bioallied Sci. 2023;15(3):152–157. doi:10.4103/jpbs.jpbs
   PubMed Web of Science ®Google Scholar
• dos RTM, Guidoni CM, Girotto E, et al. Knowledge and conduct of pharmacists for dispensing of drugs in community pharmacies: a cross-sectional study. Brazilian J Pharm Sci. 2015;51(3):733–744. doi:10.1590/S1984-82502015000300025
   Web of Science ®Google Scholar
• Borgsteede SD, Rhodius CA, De Smet PA, Pasman HRW, Onwuteaka-Philipsen BD, Rurup ML. The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians. Eur J Clin Pharmacol. 2011;67(1):79–89. doi:10.1007/s00228-010-0901-7
   PubMed Web of Science ®Google Scholar
• Bach P, Hartung D. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Addict Sci Clin Pract. 2019;14(1):30. doi:10.1186/s13722-019-0158-0
   PubMed Web of Science ®Google Scholar
• Alorfi NM, Ashour AM, Algarni AS, Alsolami FA, Alansari AM, Tobaiqy M. Assessment of the community pharmacists’ knowledge and attitudes toward pain and pain management in Saudi Arabia. Int J Gen Med. 2022;15(November):8527–8537. doi:10.2147/IJGM.S387066
   PubMedGoogle Scholar
• Werremeyer A, Mosher S, Eukel H, et al. Pharmacists’ stigma toward patients engaged in opioid misuse: when “social distance” does not mean disease prevention. Subst Abus. 2021;42(4):919–926. doi:10.1080/08897077.2021.1900988
   PubMed Web of Science ®Google Scholar
• Cochran G, Field C, Lawson K. Pharmacists’ knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists. 2013:71–79. DOI:10.1111/jphs.12013
   Google Scholar
• Hall EA, Cernasev A, Nasritdinova U, Veve MP, Hohmeier KC. Stigma of opioid use disorder and its indirect effects on student pharmacists’ perceptions and attitudes. Pharmacy. 2020;8(3):144. doi:10.3390/pharmacy8030144
   Web of Science ®Google Scholar
• Crapanzano K, Vath RJ, Fisher D. Reducing stigma towards substance users through an educational intervention: harder than it looks. Acad Psychiatry. 2014;38(4):420–425. doi:10.1007/s40596-014-0067-1
   PubMed Web of Science ®Google Scholar
• Tomko JR, Giannetti VJ. Knowledge, attitudes, and professional practices versus personal beliefs of pharmacists regarding chemically dependent patients. Ment Heal Clin. 2013;3(6):302–308. doi:10.9740/mhc.n183649
   Google Scholar
• Powell H, Peters G. Managing opioid overdose in the hospital setting. US Pharm. 2019;44(3).
   Web of Science ®Google Scholar
• Palmar J. An examination of beliefs and opinions about drug use in relation to personal stigma- tization towards drug users. J Psych Drugs. 2013;45(5):367–373. doi:10.1080/02791072.2013.843044
   PubMed Web of Science ®Google Scholar
• Thakur T, Frey M, Chewning B. Communication between patients and health care professionals about opioid medications. Explor Res Clin Soc Pharm. 2021;2:100030. doi:10.1016/j.rcsop.2021.100030
   PubMedGoogle Scholar
• Rao D Community Pharmacists and Substance Use Disorders: Attitudes, Knowledge and Practices. Dr Diss Duquesne Univ. 2018:1–229. Available from: http://www.pqdtcn.com/thesisDetails/FDFB6143D5AC2D0DCEF3C63DEA5A45A7.Accessed February 22, 2024.
   Google Scholar